These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 24928102)

  • 1. Comparison of Glucose Measures in Patients Receiving Concomitant Paroxetine and Pravastatin to Other SSRI/Statin Combinations.
    Orrico KB; Huynh MH; Olson CW
    Ann Pharmacother; 2014 Sep; 48(9):1172-1176. PubMed ID: 24928102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels.
    Tatonetti NP; Denny JC; Murphy SN; Fernald GH; Krishnan G; Castro V; Yue P; Tsao PS; Kohane I; Roden DM; Altman RB
    Clin Pharmacol Ther; 2011 Jul; 90(1):133-42. PubMed ID: 21613990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-medication of pravastatin and paroxetine-a categorical study.
    An L; Ravindran PP; Renukunta S; Denduluri S
    J Clin Pharmacol; 2013 Nov; 53(11):1212-9. PubMed ID: 23907716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of type 2 diabetes among patients exposed to the combination of pravastatin and paroxetine.
    Gooden KM; Bibeau KB; Wood J; Irizarry MC; Pan X; Allen J; Sampson T; Heim JM
    Curr Drug Saf; 2015; 10(2):152-8. PubMed ID: 24861991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of diagnostic cluster methodology for therapeutic costing and drug surveillance of HMG-CoA reductase-inhibitor therapy.
    Bottorff MB; Yenkowsky JP; Cave DG
    Clin Ther; 1999 Jan; 21(1):218-35. PubMed ID: 10090437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome.
    Güçlü F; Ozmen B; Hekimsoy Z; Kirmaz C
    Biomed Pharmacother; 2004 Dec; 58(10):614-8. PubMed ID: 15589072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
    Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
    Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases.
    Ming EE; Davidson MH; Gandhi SK; Marotti M; Miles CG; Ke X; McKenney JM
    J Clin Lipidol; 2008 Dec; 2(6):453-63. PubMed ID: 21291779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia.
    Li JJ; Li YS; Chu JM; Zhang CY; Wang Y; Huang Y; Chen J; Yuan JQ; Huang YL
    Clin Chim Acta; 2006 Apr; 366(1-2):269-73. PubMed ID: 16343471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of escitalopram vs paroxetine on severe depression with associated anxiety: data from the "Boulenger" study].
    Chauvet-Gélinier JC
    Encephale; 2010 Oct; 36(5):425-32. PubMed ID: 21035633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxetine versus placebo: a double-blind comparison in depressed patients.
    Claghorn JL; Kiev A; Rickels K; Smith WT; Dunbar GC
    J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-administration of paroxetine increased the systemic exposure of pravastatin in diabetic rats due to the decrease in liver distribution.
    Li F; Xu D; Shu N; Zhong Z; Zhang M; Liu C; Ling Z; Liu L; Liu X
    Xenobiotica; 2015; 45(9):794-802. PubMed ID: 25915109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high-dose pitavastatin on glucose homeostasis in patients at elevated risk of new-onset diabetes: insights from the CAPITAIN and PREVAIL-US studies.
    Chapman MJ; Orsoni A; Robillard P; Hounslow N; Sponseller CA; Giral P
    Curr Med Res Opin; 2014 May; 30(5):775-84. PubMed ID: 24328357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
    Cooke CE; Hammerash WJ
    Clin Ther; 2006 Apr; 28(4):591-9. PubMed ID: 16750470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions.
    Pamer CA; Hammad TA; Wu YT; Kaplan S; Rochester G; Governale L; Mosholder AD
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):158-74. PubMed ID: 20049836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy.
    Roscoe JA; Morrow GR; Hickok JT; Mustian KM; Griggs JJ; Matteson SE; Bushunow P; Qazi R; Smith B
    Breast Cancer Res Treat; 2005 Feb; 89(3):243-9. PubMed ID: 15754122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.